Blood Flow Calculators
0 calculators tagged with “Blood Flow”
All Calculators
No calculators found for this topic.
Hagen-Poiseuille Law for Blood Flow
Q = πr⁴ΔP / (8ηL)
Q = flow rate (mL/s); r = radius (cm); ΔP = pressure gradient (mmHg or Pa); η = blood viscosity (~0.03 poise or 3 mPa·s); L = vessel length (cm).
Vascular resistance: R = 8ηL/(πr⁴). Blood flow: Q = ΔP/R. Q ∝ r⁴: doubling radius → 16× flow.
Cardiac Output
Q_cardiac = HR × SV. HR = heart rate (beats/min); SV = stroke volume (mL/beat). Normal: 70 bpm × 70 mL = 4,900 mL/min ≈ 5 L/min. During maximal exercise (trained athlete): up to 25 L/min. CO = ΔP / total peripheral resistance (TPR). Blood pressure = CO × TPR.
Peripheral Resistance Control
Arterioles regulate Q by changing diameter: vasodilation (increased r) → dramatically increased flow to tissue. Vasoconstriction (decreased r) → reduced flow. Regulated by: sympathetic nervous system (α₁ receptors → vasoconstriction; β₂ → vasodilation in skeletal muscle); local metabolites (CO₂, H⁺, adenosine → vasodilation in active tissue); hormones (epinephrine, angiotensin II, nitric oxide).
Fahraeus-Lindqvist Effect
In vessels < 300 μm diameter: red blood cells migrate to center → cell-free plasma layer at wall → apparent viscosity decreases. Relevant in capillaries and small arterioles.
Glossary
Frequently Asked Questions
Blood flow follows Hagen-Poiseuille law: Q = πr⁴ΔP/(8ηL). The critical relationship: Q ∝ r⁴. Small changes in radius produce dramatic changes in flow: 10% radius reduction (e.g., from mild vasoconstriction): Q ∝ 0.9⁴ = 0.656 → 34% decrease in flow. 50% radius reduction (e.g., from severe arterial stenosis): Q ∝ 0.5⁴ = 0.0625 → 94% decrease in flow. 2× vasodilation (doubling radius): Q increases 16-fold. This is why: arteriole diameter is the primary regulator of tissue blood flow (vasodilation/constriction by 10–30% dramatically alters flow); arterial stenosis (narrowing) rapidly reduces downstream blood flow; antihypertensive vasodilators substantially lower blood pressure and increase organ perfusion even with modest vasodilation.
Cardiac output (CO) = heart rate (HR) × stroke volume (SV). HR = beats per minute; SV = volume ejected per beat. Normal resting values: HR = 60–80 bpm; SV = 60–80 mL/beat; CO = 4–6 L/min. Distribution: the heart pumps the entire blood volume (~5 L) approximately once per minute. Blood flows to: kidneys ~20% (1 L/min); liver 25%; brain 15%; skeletal muscle 15–20% at rest (up to 80–85% during maximal exercise). Fick principle: CO = VO₂/(CaO₂ − CvO₂). Preload, afterload, and contractility (Frank-Starling mechanism) determine SV: increased venous return → more stretch → stronger contraction → higher SV (Frank-Starling law).
Ohm's law analogy: Q = ΔP / R (flow = pressure gradient / resistance). Blood pressure (mean arterial pressure, MAP) = CO × TPR, where CO = cardiac output and TPR = total peripheral resistance. MAP = diastolic + (pulse pressure/3) ≈ diastolic + 0.33 × (systolic − diastolic). Normal: MAP ≈ 93 mmHg. Regulation: blood pressure rises if either CO or TPR increases; falls if either decreases. Antihypertensive drugs: ACE inhibitors (reduce angiotensin II → vasodilation → reduce TPR); beta-blockers (reduce HR and SV → reduce CO); calcium channel blockers (vasodilation → reduce TPR); diuretics (reduce blood volume → reduce preload → reduce CO).
The Fahraeus-Lindqvist effect describes the reduction in apparent blood viscosity in small vessels (< 300 μm diameter). Mechanism: in small vessels, red blood cells (RBCs, diameter 6–8 μm) migrate toward the vessel centerline due to hydrodynamic interactions — this is called axial migration. A cell-free plasma layer forms near the vessel wall. Since the wall shear layer is now mostly low-viscosity plasma (not whole blood), apparent viscosity decreases. Effect: apparent viscosity of whole blood in large vessels ≈ 3–4 mPa·s; in capillaries (~8 μm diameter) ≈ 1.2–2 mPa·s. Relevance: Fahraeus-Lindqvist effect reduces resistance in the microcirculation; this allows tissue perfusion at lower driving pressures than predicted from whole-blood viscosity. Clinically relevant in microcirculatory disease (sickle cell, diabetes) where RBC deformability is compromised.